<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0605">
 <label>120</label>
 <element-citation publication-type="journal" id="ref0600">
  <person-group person-group-type="author">
   <name>
    <surname>Schroeder</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sotsky</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>Y.K.</given-names>
   </name>
  </person-group>
  <article-title>Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-
   <italic>N</italic>-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus
  </article-title>
  <source>J Med Chem</source>
  <volume>57</volume>
  <issue>20</issue>
  <year>2014</year>
  <fpage>8608</fpage>
  <lpage>8621</lpage>
  <pub-id pub-id-type="pmid">25244572</pub-id>
 </element-citation>
</ref>
